| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/04/2012 | CN102302561A Method for preparing belvedere fruit total saponins |
| 01/04/2012 | CN102302557A Continuous extraction method of natural alpha-glucosidase inhibitor |
| 01/04/2012 | CN102302549A Drug composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 01/04/2012 | CN102302545A Dai medicine extract with blood-sugar reducing activity, preparation method, composition and application |
| 01/04/2012 | CN102302539A Method for producing trifolium pratense L. isoflavones |
| 01/04/2012 | CN102302536A Drug for treating diabetes mellitus |
| 01/04/2012 | CN102302533A Application of brassica rapa organic acid to preparation of medicaments for reducing blood sugar |
| 01/04/2012 | CN102302520A Composition of chromium malate and bee glue and application thereof |
| 01/04/2012 | CN102302512A Multi-vitamin mineral tablet |
| 01/04/2012 | CN102302494A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 01/04/2012 | CN102302489A Preparation method of compound amino acid injection |
| 01/04/2012 | CN102302452A Pitavastatin calcium lipid solid preparation |
| 01/04/2012 | CN102302449A Oil-in-water cinnamic aldehyde nano emulsion medicament |
| 01/04/2012 | CN102302159A Health food or medicine capable of reducing blood glucose level of diabetic and preparation method thereof |
| 01/04/2012 | CN102302153A Health-care composition and preparation method and application thereof |
| 01/04/2012 | CN102048885B Extraction process for lychee seed saponin |
| 01/04/2012 | CN101978979B Method for preparing refined celery extract |
| 01/04/2012 | CN101954030B Oral medicament for treating diabetes mellitus |
| 01/04/2012 | CN101875636B Imidazoline-2,4-diketone derivative and preparation method and applications thereof |
| 01/04/2012 | CN101836969B Dry ice defatting pill |
| 01/04/2012 | CN101810636B Application of Chinese yam polysaccharide in preparation of medicament for treating obesity |
| 01/04/2012 | CN101732286B Voglibose film and preparation method thereof |
| 01/04/2012 | CN101708295B Chinese medicinal preparation for treating diabetes and preparation methods thereof |
| 01/04/2012 | CN101658498B Freeze-drying manufactured product of cytidine triphosphate disodium and arginine and preparation method thereof |
| 01/04/2012 | CN101618216B Direct compression formulation and process |
| 01/04/2012 | CN101564398B Multivitamin soft capsule and preparation method thereof |
| 01/04/2012 | CN101541323B Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 01/04/2012 | CN101528708B Indazole derivatives useful as l-cpt1 inhibitors |
| 01/04/2012 | CN101472565B Preparation method of granular formulation |
| 01/04/2012 | CN101439027B Effervescent tablet containing L-carnitine-L-tartrate |
| 01/04/2012 | CN101347422B Uses of salvianolic acid A in preventing and/or treating diabetes and complication |
| 01/04/2012 | CN101313900B Hydroxy fatty acid oligomer and application in regulating calcium ion concentration in cell |
| 01/04/2012 | CN101292741B Health care bamboo salt with mind pacifying and digestion promoting function, and method of preparing the same |
| 01/04/2012 | CN101292728B Method for extracting nutriment from Chinese date and iron stick yam |
| 01/04/2012 | CN101155783B Pyrazoles |
| 01/04/2012 | CN101094657B Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof |
| 01/04/2012 | CN101057675B Health-care food capable of auxiliary reducing blood sugar and its preparing process |
| 01/03/2012 | US8088974 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 01/03/2012 | US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof |
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088768 Protein kinase and phosphatase inhibitors |
| 01/03/2012 | US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/03/2012 | US8088731 Use of GLP-1 compound for treatment of critically ill patients |
| 01/03/2012 | US8088730 Ghrelin variant protein |
| 01/03/2012 | US8088419 Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
| 01/03/2012 | US8088410 25-hydroxy Vitamin D3 compositions |
| 01/03/2012 | CA2690293C Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 01/03/2012 | CA2655692C Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1) |
| 01/03/2012 | CA2576256C Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 01/03/2012 | CA2486712C Method of treating diabetes |
| 01/03/2012 | CA2481321C [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
| 01/03/2012 | CA2468910C Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 01/03/2012 | CA2466286C Composition and method |
| 01/03/2012 | CA2463134C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/03/2012 | CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 01/03/2012 | CA2455972C N6-benzyl and phenyl substituted adenines and their use as cosmetics, pharmaceutical preparations and plant growth regulators |
| 01/03/2012 | CA2446254C New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits |
| 01/03/2012 | CA2445835C 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 01/03/2012 | CA2388180C Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 01/02/2012 | CA2745113A1 Nutritional or dietary supplement composition and methods for using same for treating visual acuity loss |
| 12/29/2011 | WO2011163533A2 One step removal of selected molecules from body fluid and tissue |
| 12/29/2011 | WO2011163231A2 Combination therapy for the treatment of diabetes |
| 12/29/2011 | WO2011162633A1 Soft cationic mitochondrial uncouplers |
| 12/29/2011 | WO2011162368A1 Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
| 12/29/2011 | WO2011162320A1 Combination of egcg or methylated egcg and a pde inhibitor |
| 12/29/2011 | WO2011162267A1 Novel thiophenecarboxamide derivatives and use thereof as medicine |
| 12/29/2011 | WO2011162234A1 Composition which is used for purpose of inhibiting biosynthesis of cholesterol |
| 12/29/2011 | WO2011162115A1 PHARMACEUTICAL COMPOSITION UTILIZING PANCREATIC β CELL PROLIFERATION FACTOR |
| 12/29/2011 | WO2011161964A1 Agent for improving insulin resistance with acat inhibitor as active component |
| 12/29/2011 | WO2011161521A1 Compositions comprising metformin and rosiglitazone |
| 12/29/2011 | WO2011160974A2 Statin derivatives |
| 12/29/2011 | WO2011160444A1 Pharmaceutical composition comprising vanadium and its use |
| 12/29/2011 | WO2011160443A1 Pharmaceutical composition comprising vanadium and its use |
| 12/29/2011 | WO2011160434A1 Preparing process and quality controlling method for an compound injection |
| 12/29/2011 | WO2011135194A3 Method for diagnosing risk of type 1 diabetes and for preventing onset of type 1 diabetes |
| 12/29/2011 | WO2011100376A3 Methods and architecture for power optimization of iontophoretic transdermal drug delivery |
| 12/29/2011 | WO2011097500A3 The tweak/fn14 system regulates skeletal muscle atrophy and regeneration |
| 12/29/2011 | WO2011091366A3 Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| 12/29/2011 | WO2011089168A3 Special composition for the use thereof as a drug |
| 12/29/2011 | WO2010132882A8 Sublingual dexmedetomidine compositions and methods of use thereof |
| 12/29/2011 | WO2010129138A3 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment |
| 12/29/2011 | US20110319870 Method for increasing the pool of ngn3+ endocrine progenitor cells and pancreatic endocrine cell mass |
| 12/29/2011 | US20110319499 Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease |
| 12/29/2011 | US20110319497 Ampk activator |
| 12/29/2011 | US20110319496 Process for the preparation of ajoene |
| 12/29/2011 | US20110319494 Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents |
| 12/29/2011 | US20110319482 Novel treatments |
| 12/29/2011 | US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
| 12/29/2011 | US20110319475 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
| 12/29/2011 | US20110319471 Lna antagonists targeting the androgen receptor |
| 12/29/2011 | US20110319469 SNPs of Apolipoprotein B and Modulation of Their Expression |
| 12/29/2011 | US20110319460 Kinase inhibitors |
| 12/29/2011 | US20110319458 Compound with agitation effect on peroxisome proliferator-activated receptor. process for its preparation and use thereof |
| 12/29/2011 | US20110319451 5-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders |
| 12/29/2011 | US20110319449 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
| 12/29/2011 | US20110319440 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds |
| 12/29/2011 | US20110319439 Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
| 12/29/2011 | US20110319438 Novel sulfonamides as l-cpt1 inhibitors |
| 12/29/2011 | US20110319436 Methods and Compositions for Modulating IRE1, SRC, and ABL Activity |
| 12/29/2011 | US20110319434 Bicyclic Heterocyclic Derivatives and Methods of Use Thereof |